Site Editor

Rebecca Olin, MD, MS


Andrew H. Wei, MBBS, PhD, on Oral Azacitidine as Maintenance Therapy in AML: Clinical Challenges

Posted: Sunday, March 1, 2020

Andrew H. Wei, MBBS, PhD, of The Alfred Hospital, Melbourne, talks about the clinical challenges of encouraging and monitoring adherence, managing side effects, and other issues relevant to treating older patients with acute myeloid leukemia.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.